Navigation Links
Halting Bone-Building Osteoporosis Drug Use Cuts Risk for Additional Atypical Femur Fracture in Half
Date:2/8/2012

SAN FRANCISCO, Feb. 8, 2012 /PRNewswire-USNewswire/ -- There is growing evidence that supports an association between atypical fractures of the femur – a rare break of the thigh bone, typically without trauma – and the use of bisphosphonates, drugs proven to enhance bone density and reduce fracture incidence caused by osteoporosis. While the risk for suffering an atypical femur fracture while taking bisphosphonates is still very small – just 1 in 1,000 patients after six years of treatment – research presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that discontinuing bisphosphonate use following an atypical femur fracture can significantly lower the risk for a subsequent atypical fracture.

Scientists believe that bisphosphonates may suppress the body's natural process of remodeling – where old bone tissue is replaced with new, healthy tissue – in some patients, resulting in brittle bones susceptible to atypical fractures, especially in the femur.

Investigators reviewed femur fracture data from Jan. 1, 2007 until Dec. 31, 2009 in patients older than 45 enrolled in a large California HMO. There were 126 patients with an atypical femur fracture who reportedly took bisphosphonates prior to their bone break.

The incidence of a subsequent atypical femur fracture occurring in the other thigh was 53.9 percent in patients who continued bisphosphonates for three or more years after their first fracture, compared to 19.3 percent in patients who discontinued bisphosphonate use. Overall, subsequent atypical femur fractures were decreased by 65.6 percent when bisphosphonates were stopped within one year following the first fracture.

"The risk of a contralateral atypical femur fracture (on the opposite side) increases over tim
'/>"/>

SOURCE American Academy of Orthopaedic Surgeons
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015
2. Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
3. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
4. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
5. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
6. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
7. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
8. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
9. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
10. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
11. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 22. Mai 2013 Ranbaxy ... Tochtergesellschaft von Daiichi Sankyo Co., Ltd. ... 22. Mai die Maßnahmen bekannt, die ... hat, um sich der Angelegenheiten der ... http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). Daiichi Sankyo ...
(Date:5/22/2013)... May 22, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or ... products, announced today that the Company will present at the ... 2013 at the Le Parker Meridian hotel, 119 W. 56 ... . The presentation is scheduled to begin at 2:15 p.m. ... Heska Heska Corporation (NASDAQ: HSKA - ...
(Date:5/22/2013)... May 22, 2013  Team Health Holdings Inc. ("TeamHealth") ... suppliers of outsourced healthcare professional staffing and administrative services ... the United States , today announced that its ... Bank Healthcare Conference held on May 29, 2013 at ... 8:00 AM eastern time.  Interested investors and other parties ...
Breaking Medicine Technology:Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2
... THE WOODLANDS, Texas , Jan. 25 In response ... York Times article, " Radiation Offers New Cures and Ways to ... patients and the general public understand that the benefits received from radiation therapy ... disease with help from the US Oncology physician network, and their loved ones, ...
... , , , MOUNTAIN VIEW, Calif. ... enrollment of its pivotal US study for the ArterX Vascular ... patients who were scheduled to receive a synthetic vascular graft ... applications involved the placement of arteriovenous dialysis access grafts, carotid ...
Cached Medicine Technology:Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 2Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 3Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study 2
(Date:5/23/2013)... Better Life Maids of Portland Oregon is putting on ... one of a kind green house cleaning service in the ... May 29th, and a soft opening scheduled for June 3rd, ... in Portland recently and will travel to St. Louis June ... really is a lot to take in" stated Heather Richardson. ...
(Date:5/23/2013)... 23, 2013 Footwear etc. is pleased to ... Collection of sandals containing cork footbeds. Known for its extremely ... good sales for many years, and with this new collection ... , Dansko Shoes and Sandals are renowned ... is no exception. Containing leather and patent leather uppers in ...
(Date:5/23/2013)... Long-Term Care Insurance shopping site LTC Tree has ... for Long Term Care Insurance are approved by insurance companies ... to buy a Long Term Care Insurance policy is an ... purchase protection are increasingly being turned away by insurance companies, ... variety of chronic conditions appear to be responsible for the ...
(Date:5/23/2013)... AttorneyOne.com, a recognized authority on law, ... providing expert opinion in view of the recent news ... to court documents, on March 5, 2013 a woman ... no. 3:2013cv50102) alleging that her husband suffered massive brain ... is mainly used as a blood thinner for patients ...
(Date:5/22/2013)... St. Petersburg, FL (PRWEB) May 23, 2013 ... rarely affects men due to several factors, including estrogen ... Cellulite is essentially toxins and fatty deposits stored and ... skin. "To diminish cellulite, one must take a multi-pronged ... These multi-pronged actions include: , Specific products like ...
Breaking Medicine News(10 mins):Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2Health News:Get Cellulite Under Control Now with Cellulite Whisperer® Products Introduced by Sublime Beauty® 2
... H1N1 in a cat or pigs are likely very rare, experts ... news broke on Wednesday that a domestic cat had come down ... owners, many people no doubt wondered how vulnerable their own pets ... protecting from this strain of flu? The answer, experts say, is ...
... EF Johnson Technologies, Inc. (Nasdaq: EFJI ) ... results for the quarter ending September 30, 2009, and ... 4:30 p.m. Eastern Time on Thursday, November 12, 2009. ... Jana Ahlfinger Bell, executive vice president and chief financial ...
... , PURCHASE, N.Y., Nov. 4 Nutrition 21, Inc. ... ingredients and finished products under the Iceland Health®, Chromax®, ... sugar levels, improve cardiovascular health, enhance memory and reduce ... first quarter of fiscal year 2010 ended September 30, ...
... differently than Gardasil, Cervarix, it targets inside of virus, ... A vaccine that targets human papillomavirus (HPV) is able ... into full-blown malignancies, Dutch researchers report. , Two other ... for young women to prevent infection with HPV, which ...
... Inc. (Nasdaq: GHDX ) today reported financial results and business ... increased to $39.5 million in the third quarter of 2009 compared ... revenue from the Onco type DX® breast cancer test was ... 39 percent, compared with $28.1 million in the third quarter of ...
... Nov. 4 (HealthDay News) -- Eating too fast can lead ... hormones in the gut that trigger the feeling of being ... ate 300 milliliters of ice cream at different rates. Blood ... before and after consumption of the ice cream. Participants who ...
Cached Medicine News:Health News:Rest Easy. When It Comes to Swine Flu, Your Pet Is Safe 2Health News:Rest Easy. When It Comes to Swine Flu, Your Pet Is Safe 3Health News:EF Johnson Technologies, Inc. Announces Third Quarter Financial Reporting Date 2Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 2Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 3Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 4Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 5Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 6Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 2Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 2Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 4Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 5Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 6Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 7Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 8Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 9Health News:Fast Eating Limits Gut Hormones That Induce Fullness 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: